Registration
ALB SOLUTIONS for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Firm
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to regulatory and legislative developments regarding biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM BUCKALEW New | Covered Official Positions Continued: Deputy Chief of Staff, U.S. Rep. Markwayne Mullin (R-OK); Communications Director & Legislative Assistant, U.S. Rep. Gregg Harper (R-MS) |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH | Germany | Germany | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.